Matt brings a unique blend of commercial go-to-market experience and government policy expertise. Matt was most recently the marketing director at T2 Biosystems, a growth-stage public diagnostic company, where he led the team to record sepsis test sales and doubling of new clinical evidence. In a previous commercial operations role at the company, he led new market expansion and the first capital equipment sales in Australia, Asia, and Latin America.
Prior to his work in the private sector, Matt was the policy director for the Governor of North Carolina and NC Secretary of Health and Human Services, serving as lead advisor for the state’s historic Medicaid reform. Matt holds a bachelor’s degree in English from Georgetown University.
Contact Matt at matt@racetrack.health
Merel is a highly successful international business leader with 25+ years of experience in the healthcare diagnostic industry. Most recently, as Senior Director of International Business at T2 Biosystems, she grew the company's international presence to 48 countries (Europe, Middle East, Asia/Pacific, and Mexico). Under her leadership, international test sales grew 3x from 2019-2024 and she achieved record capital instrument sales and won multiple awards.
Her expertise spans strategic sales planning, business development, distribution management, and product management, with deep focus on in-vitro diagnostics, molecular tests and novel biomarkers for the laboratory and point-of-care, in various diagnostic products including products for sepsis, ICU, cardiology, emergency medicine, infectious diseases, coagulation, and oncology in international markets. Prior to her business career, Merel was a field hockey goalie in the top women's league in the Netherlands.
Contact Merel at merel@racetrack.health